Abbott Laboratories Price Today
Abbott Laboratories
ABT
Healthcare
$191.77B
💰
Market Cap
33.9
💸
Price to Earnings
$3.3
🎉
EPS
+75
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
14 |
Strong Buy |
8 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
ABT Price Forecast Target
110.5 👉 130.0 +18%
ABT EPS Forecast
3.3 👉 4.7 +44%
Financials
Profit Margin
14 %
Revenue Growth
1.5 %
Dividend
$ 2.2
Held Percent
0.5% - Insiders
77.0% - Institutions
22.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $17.3B
-
💰 Blackrock Inc. $14.8B
-
💰 Capital Research Global Investors $9.6B
-
💰 State Street Corporation $8.3B
-
💰 Capital International Investors $7.1B
Stock Ideas
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…📮FAQ
Some Frequently Asked Questions.
The Abbott Laboratories industry is Medical Devices
The Abbott Laboratories sector is Healthcare
The Abbott Laboratories forecasted predicted Price to Earnings PE ratio is 23.5
The Abbott Laboratories Price to Earnings PE ratio is 33.9
The Market Capitalization of Abbott Laboratories is $191.77B
There are total of 1723870887 float shares with 77.0% held by Institutions and 0.5% held by insiders
The MAbbott Laboratories forecasted Earnings per Share EPS is $4.7
The Abbott Laboratories Earnings per Share EPS is 3.3
The Abbott Laboratories company has $0 gross profits with 14 profit margins
The Abbott Laboratories Earnings Growth is 0.55% with 0.543% quarterly earnings growth
The Abbott Laboratories Revenue is $40108998656 with 0.015 revenue growth
The price target for Abbott Laboratories stock is $130.0 for the high target and $98.6 for the low target
The consensus analyst recommendations for Abbott Laboratories is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Abbott Laboratories is Buy, with the following breakdown:
- Buy: 14
- Strong Buy: 8
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of Abbott Laboratories is 0.7
The dividend of Abbott Laboratories is $2.2
The dividend yield of Abbott Laboratories is 0.0199%
The biggest institutional and mutual fund holders of Abbott Laboratories stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital Research Global Investors
- State Street Corporation
The Abbott Laboratories ESG Score is 75, with the following breakdown:
- E: 2.27
- S: 14.24
- G: 8.33